The American Diabetes Association is soliciting research proposals that leverage precision medicine-based approaches at all stages in the course type 1 diabetes and type 2 diabetes. While this call is broad in scope and encompasses basic through clinical research, significant emphasis will be placed on clinical research and translation. Applicants should explain how their proposal directly aligns with precision diagnostics, therapeutics, treatment, prognostics or monitoring, as outlined in the Precision Medicine Diabetes Initiative's first consensus report in 2020(link is external), (Diabetes Care® 2020 Jul;43(7):1617-1635). Importantly, submissions should indicate how the proposed research will have a significant impact (“move the needle”) on outcomes in those individuals living with diabetes.
